Table 4: Compare the mean of NCV in treated patients with sodium valproate by type of nerves.

Type of nerves

Drugs

Mean

P -value

Median

 

sodium valproate in baseline

53.4

0.003

 

Control

58.7

Median

 

sodium valproate in baseline

53.4

0.072

 

sodium valproate six month late

53.3

Ulnar

 

sodium valproate in baseline

50.1

0.0002

 

Control

50.8

Ulnar

 

sodium valproate in baseline

50.1

0.068

 

sodium valproate six month late

50.08

Sural

 

sodium valproate in Baseline

47.5

0.004

 

Control

50.6

Sural

 

sodium valproate in baseline

47.5

0.1

 

sodium valproate six month late

47.8

Peroneal

 

sodium valproate in baseline

46.8

0.046

 

Control

46.4

Peroneal

sodium valproate in baseline

46.8

0.095

sodium valproate six month late

46.75